nodes	percent_of_prediction	percent_of_DWPC	metapath
Vigabatrin—L-Glutamine—TGM3—skin cancer	0.0374	1	CrCbGaD
Vigabatrin—GABBR1—hair follicle—skin cancer	0.00732	0.345	CbGeAlD
Vigabatrin—GABBR1—nipple—skin cancer	0.00496	0.234	CbGeAlD
Vigabatrin—SLC36A1—female reproductive system—skin cancer	0.00195	0.092	CbGeAlD
Vigabatrin—SLC36A1—head—skin cancer	0.00163	0.0768	CbGeAlD
Vigabatrin—ABAT—head—skin cancer	0.00162	0.0764	CbGeAlD
Vigabatrin—Erectile dysfunction—Temozolomide—skin cancer	0.00158	0.00168	CcSEcCtD
Vigabatrin—Weight increased—Temozolomide—skin cancer	0.00156	0.00166	CcSEcCtD
Vigabatrin—Pneumonia—Temozolomide—skin cancer	0.00154	0.00164	CcSEcCtD
Vigabatrin—Infestation NOS—Temozolomide—skin cancer	0.00153	0.00163	CcSEcCtD
Vigabatrin—Infestation—Temozolomide—skin cancer	0.00153	0.00163	CcSEcCtD
Vigabatrin—Depression—Temozolomide—skin cancer	0.00153	0.00162	CcSEcCtD
Vigabatrin—Stevens-Johnson syndrome—Temozolomide—skin cancer	0.00152	0.00161	CcSEcCtD
Vigabatrin—Body temperature increased—Vemurafenib—skin cancer	0.00151	0.0016	CcSEcCtD
Vigabatrin—Neuropathy peripheral—Temozolomide—skin cancer	0.0015	0.00159	CcSEcCtD
Vigabatrin—Urinary tract infection—Temozolomide—skin cancer	0.00149	0.00158	CcSEcCtD
Vigabatrin—Musculoskeletal discomfort—Imiquimod—skin cancer	0.00148	0.00158	CcSEcCtD
Vigabatrin—Deafness—Docetaxel—skin cancer	0.00148	0.00157	CcSEcCtD
Vigabatrin—Insomnia—Imiquimod—skin cancer	0.00147	0.00157	CcSEcCtD
Vigabatrin—Upper respiratory tract infection—Fluorouracil—skin cancer	0.00147	0.00156	CcSEcCtD
Vigabatrin—Paraesthesia—Imiquimod—skin cancer	0.00146	0.00155	CcSEcCtD
Vigabatrin—GABBR1—lymph node—skin cancer	0.00145	0.0685	CbGeAlD
Vigabatrin—Somnolence—Imiquimod—skin cancer	0.00145	0.00154	CcSEcCtD
Vigabatrin—Hepatobiliary disease—Temozolomide—skin cancer	0.00145	0.00154	CcSEcCtD
Vigabatrin—Erythema multiforme—Dactinomycin—skin cancer	0.00144	0.00153	CcSEcCtD
Vigabatrin—Sinusitis—Temozolomide—skin cancer	0.00144	0.00153	CcSEcCtD
Vigabatrin—Dyspepsia—Imiquimod—skin cancer	0.00143	0.00152	CcSEcCtD
Vigabatrin—Pneumonia—Fluorouracil—skin cancer	0.00142	0.00151	CcSEcCtD
Vigabatrin—Decreased appetite—Imiquimod—skin cancer	0.00142	0.0015	CcSEcCtD
Vigabatrin—Infestation NOS—Fluorouracil—skin cancer	0.00141	0.0015	CcSEcCtD
Vigabatrin—Infestation—Fluorouracil—skin cancer	0.00141	0.0015	CcSEcCtD
Vigabatrin—Hypersensitivity—Vemurafenib—skin cancer	0.00141	0.0015	CcSEcCtD
Vigabatrin—Gastrointestinal disorder—Imiquimod—skin cancer	0.00141	0.00149	CcSEcCtD
Vigabatrin—Fatigue—Imiquimod—skin cancer	0.0014	0.00149	CcSEcCtD
Vigabatrin—Pain—Imiquimod—skin cancer	0.00139	0.00148	CcSEcCtD
Vigabatrin—Neuropathy peripheral—Fluorouracil—skin cancer	0.00138	0.00147	CcSEcCtD
Vigabatrin—Urinary tract infection—Fluorouracil—skin cancer	0.00137	0.00146	CcSEcCtD
Vigabatrin—Conjunctivitis—Fluorouracil—skin cancer	0.00137	0.00146	CcSEcCtD
Vigabatrin—Asthenia—Vemurafenib—skin cancer	0.00137	0.00146	CcSEcCtD
Vigabatrin—Hallucination—Temozolomide—skin cancer	0.00137	0.00145	CcSEcCtD
Vigabatrin—Hypoaesthesia—Temozolomide—skin cancer	0.00137	0.00145	CcSEcCtD
Vigabatrin—Oedema peripheral—Temozolomide—skin cancer	0.00135	0.00144	CcSEcCtD
Vigabatrin—Pruritus—Vemurafenib—skin cancer	0.00135	0.00144	CcSEcCtD
Vigabatrin—Connective tissue disorder—Temozolomide—skin cancer	0.00135	0.00143	CcSEcCtD
Vigabatrin—Lethargy—Docetaxel—skin cancer	0.00135	0.00143	CcSEcCtD
Vigabatrin—Feeling abnormal—Imiquimod—skin cancer	0.00134	0.00143	CcSEcCtD
Vigabatrin—Gastrointestinal pain—Imiquimod—skin cancer	0.00133	0.00142	CcSEcCtD
Vigabatrin—Visual impairment—Temozolomide—skin cancer	0.00132	0.00141	CcSEcCtD
Vigabatrin—Sinusitis—Fluorouracil—skin cancer	0.00132	0.00141	CcSEcCtD
Vigabatrin—Gastrointestinal haemorrhage—Docetaxel—skin cancer	0.00132	0.0014	CcSEcCtD
Vigabatrin—Pain in extremity—Docetaxel—skin cancer	0.00132	0.0014	CcSEcCtD
Vigabatrin—Ill-defined disorder—Bleomycin—skin cancer	0.00132	0.0014	CcSEcCtD
Vigabatrin—Anaemia—Bleomycin—skin cancer	0.00131	0.00139	CcSEcCtD
Vigabatrin—Diarrhoea—Vemurafenib—skin cancer	0.00131	0.00139	CcSEcCtD
Vigabatrin—Erythema multiforme—Temozolomide—skin cancer	0.0013	0.00138	CcSEcCtD
Vigabatrin—Urticaria—Imiquimod—skin cancer	0.00129	0.00137	CcSEcCtD
Vigabatrin—Abdominal pain—Imiquimod—skin cancer	0.00129	0.00137	CcSEcCtD
Vigabatrin—Body temperature increased—Imiquimod—skin cancer	0.00129	0.00137	CcSEcCtD
Vigabatrin—Eye disorder—Temozolomide—skin cancer	0.00128	0.00136	CcSEcCtD
Vigabatrin—Tinnitus—Temozolomide—skin cancer	0.00128	0.00136	CcSEcCtD
Vigabatrin—Malaise—Bleomycin—skin cancer	0.00128	0.00136	CcSEcCtD
Vigabatrin—Dizziness—Vemurafenib—skin cancer	0.00126	0.00134	CcSEcCtD
Vigabatrin—Hypoaesthesia—Fluorouracil—skin cancer	0.00126	0.00134	CcSEcCtD
Vigabatrin—Ataxia—Docetaxel—skin cancer	0.00124	0.00132	CcSEcCtD
Vigabatrin—Cough—Bleomycin—skin cancer	0.00124	0.00131	CcSEcCtD
Vigabatrin—Ill-defined disorder—Dactinomycin—skin cancer	0.00123	0.0013	CcSEcCtD
Vigabatrin—Anaemia—Dactinomycin—skin cancer	0.00122	0.0013	CcSEcCtD
Vigabatrin—Vomiting—Vemurafenib—skin cancer	0.00121	0.00129	CcSEcCtD
Vigabatrin—Chest pain—Bleomycin—skin cancer	0.00121	0.00128	CcSEcCtD
Vigabatrin—Myalgia—Bleomycin—skin cancer	0.00121	0.00128	CcSEcCtD
Vigabatrin—Abdominal pain upper—Docetaxel—skin cancer	0.00121	0.00128	CcSEcCtD
Vigabatrin—Rash—Vemurafenib—skin cancer	0.0012	0.00128	CcSEcCtD
Vigabatrin—Mental disorder—Temozolomide—skin cancer	0.0012	0.00128	CcSEcCtD
Vigabatrin—Dermatitis—Vemurafenib—skin cancer	0.0012	0.00128	CcSEcCtD
Vigabatrin—Hypersensitivity—Imiquimod—skin cancer	0.0012	0.00128	CcSEcCtD
Vigabatrin—Headache—Vemurafenib—skin cancer	0.0012	0.00127	CcSEcCtD
Vigabatrin—Malnutrition—Temozolomide—skin cancer	0.0012	0.00127	CcSEcCtD
Vigabatrin—Breast disorder—Docetaxel—skin cancer	0.00119	0.00127	CcSEcCtD
Vigabatrin—Discomfort—Bleomycin—skin cancer	0.00119	0.00127	CcSEcCtD
Vigabatrin—Malaise—Dactinomycin—skin cancer	0.00119	0.00127	CcSEcCtD
Vigabatrin—Toxic epidermal necrolysis—Docetaxel—skin cancer	0.00119	0.00126	CcSEcCtD
Vigabatrin—Nasopharyngitis—Docetaxel—skin cancer	0.00118	0.00125	CcSEcCtD
Vigabatrin—Asthenia—Imiquimod—skin cancer	0.00117	0.00124	CcSEcCtD
Vigabatrin—Confusional state—Bleomycin—skin cancer	0.00117	0.00124	CcSEcCtD
Vigabatrin—Oedema—Bleomycin—skin cancer	0.00116	0.00123	CcSEcCtD
Vigabatrin—Back pain—Temozolomide—skin cancer	0.00116	0.00123	CcSEcCtD
Vigabatrin—Pruritus—Imiquimod—skin cancer	0.00115	0.00122	CcSEcCtD
Vigabatrin—Infection—Bleomycin—skin cancer	0.00115	0.00122	CcSEcCtD
Vigabatrin—SLC36A1—lymph node—skin cancer	0.00114	0.0538	CbGeAlD
Vigabatrin—Nausea—Vemurafenib—skin cancer	0.00113	0.00121	CcSEcCtD
Vigabatrin—ABAT—lymph node—skin cancer	0.00113	0.0535	CbGeAlD
Vigabatrin—Vision blurred—Temozolomide—skin cancer	0.00113	0.0012	CcSEcCtD
Vigabatrin—Myalgia—Dactinomycin—skin cancer	0.00113	0.0012	CcSEcCtD
Vigabatrin—Tremor—Temozolomide—skin cancer	0.00112	0.00119	CcSEcCtD
Vigabatrin—Diarrhoea—Imiquimod—skin cancer	0.00111	0.00118	CcSEcCtD
Vigabatrin—Discomfort—Dactinomycin—skin cancer	0.00111	0.00118	CcSEcCtD
Vigabatrin—Ill-defined disorder—Temozolomide—skin cancer	0.00111	0.00118	CcSEcCtD
Vigabatrin—Anaemia—Temozolomide—skin cancer	0.00111	0.00117	CcSEcCtD
Vigabatrin—Agitation—Temozolomide—skin cancer	0.0011	0.00117	CcSEcCtD
Vigabatrin—Angioedema—Temozolomide—skin cancer	0.00109	0.00116	CcSEcCtD
Vigabatrin—Oedema—Dactinomycin—skin cancer	0.00108	0.00115	CcSEcCtD
Vigabatrin—Malaise—Temozolomide—skin cancer	0.00108	0.00115	CcSEcCtD
Vigabatrin—Dizziness—Imiquimod—skin cancer	0.00108	0.00114	CcSEcCtD
Vigabatrin—Vertigo—Temozolomide—skin cancer	0.00107	0.00114	CcSEcCtD
Vigabatrin—Infection—Dactinomycin—skin cancer	0.00107	0.00114	CcSEcCtD
Vigabatrin—Musculoskeletal discomfort—Bleomycin—skin cancer	0.00105	0.00112	CcSEcCtD
Vigabatrin—Cough—Temozolomide—skin cancer	0.00104	0.00111	CcSEcCtD
Vigabatrin—Paraesthesia—Bleomycin—skin cancer	0.00104	0.0011	CcSEcCtD
Vigabatrin—Weight increased—Docetaxel—skin cancer	0.00104	0.0011	CcSEcCtD
Vigabatrin—Vision blurred—Fluorouracil—skin cancer	0.00104	0.0011	CcSEcCtD
Vigabatrin—Convulsion—Temozolomide—skin cancer	0.00104	0.0011	CcSEcCtD
Vigabatrin—Vomiting—Imiquimod—skin cancer	0.00104	0.0011	CcSEcCtD
Vigabatrin—Rash—Imiquimod—skin cancer	0.00103	0.00109	CcSEcCtD
Vigabatrin—Dermatitis—Imiquimod—skin cancer	0.00103	0.00109	CcSEcCtD
Vigabatrin—Pneumonia—Docetaxel—skin cancer	0.00102	0.00109	CcSEcCtD
Vigabatrin—Headache—Imiquimod—skin cancer	0.00102	0.00108	CcSEcCtD
Vigabatrin—Anaemia—Fluorouracil—skin cancer	0.00102	0.00108	CcSEcCtD
Vigabatrin—Arthralgia—Temozolomide—skin cancer	0.00102	0.00108	CcSEcCtD
Vigabatrin—Myalgia—Temozolomide—skin cancer	0.00102	0.00108	CcSEcCtD
Vigabatrin—Infestation—Docetaxel—skin cancer	0.00102	0.00108	CcSEcCtD
Vigabatrin—Infestation NOS—Docetaxel—skin cancer	0.00102	0.00108	CcSEcCtD
Vigabatrin—Anxiety—Temozolomide—skin cancer	0.00102	0.00108	CcSEcCtD
Vigabatrin—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—skin cancer	0.00101	0.00107	CcSEcCtD
Vigabatrin—Stevens-Johnson syndrome—Docetaxel—skin cancer	0.00101	0.00107	CcSEcCtD
Vigabatrin—Discomfort—Temozolomide—skin cancer	0.00101	0.00107	CcSEcCtD
Vigabatrin—Decreased appetite—Bleomycin—skin cancer	0.00101	0.00107	CcSEcCtD
Vigabatrin—Neuropathy peripheral—Docetaxel—skin cancer	0.000998	0.00106	CcSEcCtD
Vigabatrin—Pain—Bleomycin—skin cancer	0.00099	0.00105	CcSEcCtD
Vigabatrin—Conjunctivitis—Docetaxel—skin cancer	0.00099	0.00105	CcSEcCtD
Vigabatrin—Confusional state—Temozolomide—skin cancer	0.000985	0.00105	CcSEcCtD
Vigabatrin—Musculoskeletal discomfort—Dactinomycin—skin cancer	0.000984	0.00104	CcSEcCtD
Vigabatrin—Oedema—Temozolomide—skin cancer	0.000976	0.00104	CcSEcCtD
Vigabatrin—Infection—Temozolomide—skin cancer	0.00097	0.00103	CcSEcCtD
Vigabatrin—Nausea—Imiquimod—skin cancer	0.000968	0.00103	CcSEcCtD
Vigabatrin—Hepatobiliary disease—Docetaxel—skin cancer	0.000963	0.00102	CcSEcCtD
Vigabatrin—Nervous system disorder—Temozolomide—skin cancer	0.000958	0.00102	CcSEcCtD
Vigabatrin—Convulsion—Fluorouracil—skin cancer	0.000955	0.00101	CcSEcCtD
Vigabatrin—Feeling abnormal—Bleomycin—skin cancer	0.000954	0.00101	CcSEcCtD
Vigabatrin—Skin disorder—Temozolomide—skin cancer	0.000948	0.00101	CcSEcCtD
Vigabatrin—Chest pain—Fluorouracil—skin cancer	0.000939	0.000997	CcSEcCtD
Vigabatrin—Myalgia—Fluorouracil—skin cancer	0.000939	0.000997	CcSEcCtD
Vigabatrin—Decreased appetite—Dactinomycin—skin cancer	0.000938	0.000997	CcSEcCtD
Vigabatrin—Fatigue—Dactinomycin—skin cancer	0.000931	0.000989	CcSEcCtD
Vigabatrin—Discomfort—Fluorouracil—skin cancer	0.000927	0.000985	CcSEcCtD
Vigabatrin—Pain—Dactinomycin—skin cancer	0.000923	0.000981	CcSEcCtD
Vigabatrin—Urticaria—Bleomycin—skin cancer	0.00092	0.000977	CcSEcCtD
Vigabatrin—Body temperature increased—Bleomycin—skin cancer	0.000915	0.000972	CcSEcCtD
Vigabatrin—Hypoaesthesia—Docetaxel—skin cancer	0.000909	0.000966	CcSEcCtD
Vigabatrin—Confusional state—Fluorouracil—skin cancer	0.000907	0.000964	CcSEcCtD
Vigabatrin—Oedema peripheral—Docetaxel—skin cancer	0.0009	0.000956	CcSEcCtD
Vigabatrin—Oedema—Fluorouracil—skin cancer	0.0009	0.000956	CcSEcCtD
Vigabatrin—Connective tissue disorder—Docetaxel—skin cancer	0.000898	0.000954	CcSEcCtD
Vigabatrin—Infection—Fluorouracil—skin cancer	0.000894	0.000949	CcSEcCtD
Vigabatrin—Feeling abnormal—Dactinomycin—skin cancer	0.00089	0.000945	CcSEcCtD
Vigabatrin—Musculoskeletal discomfort—Temozolomide—skin cancer	0.00089	0.000945	CcSEcCtD
Vigabatrin—Insomnia—Temozolomide—skin cancer	0.000883	0.000938	CcSEcCtD
Vigabatrin—Gastrointestinal pain—Dactinomycin—skin cancer	0.000883	0.000938	CcSEcCtD
Vigabatrin—Nervous system disorder—Fluorouracil—skin cancer	0.000882	0.000937	CcSEcCtD
Vigabatrin—Visual impairment—Docetaxel—skin cancer	0.000881	0.000936	CcSEcCtD
Vigabatrin—Paraesthesia—Temozolomide—skin cancer	0.000877	0.000931	CcSEcCtD
Vigabatrin—Somnolence—Temozolomide—skin cancer	0.000868	0.000922	CcSEcCtD
Vigabatrin—Erythema multiforme—Docetaxel—skin cancer	0.000864	0.000918	CcSEcCtD
Vigabatrin—Dyspepsia—Temozolomide—skin cancer	0.00086	0.000913	CcSEcCtD
Vigabatrin—Eye disorder—Docetaxel—skin cancer	0.000854	0.000907	CcSEcCtD
Vigabatrin—Abdominal pain—Dactinomycin—skin cancer	0.000853	0.000907	CcSEcCtD
Vigabatrin—Body temperature increased—Dactinomycin—skin cancer	0.000853	0.000907	CcSEcCtD
Vigabatrin—Hypersensitivity—Bleomycin—skin cancer	0.000853	0.000906	CcSEcCtD
Vigabatrin—Decreased appetite—Temozolomide—skin cancer	0.000849	0.000902	CcSEcCtD
Vigabatrin—Gastrointestinal disorder—Temozolomide—skin cancer	0.000843	0.000895	CcSEcCtD
Vigabatrin—Fatigue—Temozolomide—skin cancer	0.000842	0.000894	CcSEcCtD
Vigabatrin—Constipation—Temozolomide—skin cancer	0.000835	0.000887	CcSEcCtD
Vigabatrin—Pain—Temozolomide—skin cancer	0.000835	0.000887	CcSEcCtD
Vigabatrin—Asthenia—Bleomycin—skin cancer	0.000831	0.000882	CcSEcCtD
Vigabatrin—Musculoskeletal discomfort—Fluorouracil—skin cancer	0.00082	0.000871	CcSEcCtD
Vigabatrin—Pruritus—Bleomycin—skin cancer	0.000819	0.00087	CcSEcCtD
Vigabatrin—Insomnia—Fluorouracil—skin cancer	0.000814	0.000864	CcSEcCtD
Vigabatrin—Paraesthesia—Fluorouracil—skin cancer	0.000808	0.000858	CcSEcCtD
Vigabatrin—Feeling abnormal—Temozolomide—skin cancer	0.000805	0.000855	CcSEcCtD
Vigabatrin—Mental disorder—Docetaxel—skin cancer	0.000801	0.000851	CcSEcCtD
Vigabatrin—Somnolence—Fluorouracil—skin cancer	0.0008	0.00085	CcSEcCtD
Vigabatrin—Gastrointestinal pain—Temozolomide—skin cancer	0.000798	0.000848	CcSEcCtD
Vigabatrin—Malnutrition—Docetaxel—skin cancer	0.000796	0.000845	CcSEcCtD
Vigabatrin—Hypersensitivity—Dactinomycin—skin cancer	0.000795	0.000845	CcSEcCtD
Vigabatrin—Dyspepsia—Fluorouracil—skin cancer	0.000792	0.000841	CcSEcCtD
Vigabatrin—Decreased appetite—Fluorouracil—skin cancer	0.000782	0.000831	CcSEcCtD
Vigabatrin—Gastrointestinal disorder—Fluorouracil—skin cancer	0.000777	0.000825	CcSEcCtD
Vigabatrin—Urticaria—Temozolomide—skin cancer	0.000776	0.000824	CcSEcCtD
Vigabatrin—Asthenia—Dactinomycin—skin cancer	0.000775	0.000823	CcSEcCtD
Vigabatrin—Body temperature increased—Temozolomide—skin cancer	0.000772	0.00082	CcSEcCtD
Vigabatrin—Abdominal pain—Temozolomide—skin cancer	0.000772	0.00082	CcSEcCtD
Vigabatrin—Back pain—Docetaxel—skin cancer	0.00077	0.000818	CcSEcCtD
Vigabatrin—Pain—Fluorouracil—skin cancer	0.000769	0.000817	CcSEcCtD
Vigabatrin—Muscle spasms—Docetaxel—skin cancer	0.000765	0.000813	CcSEcCtD
Vigabatrin—Feeling abnormal—Fluorouracil—skin cancer	0.000741	0.000788	CcSEcCtD
Vigabatrin—Diarrhoea—Dactinomycin—skin cancer	0.000739	0.000785	CcSEcCtD
Vigabatrin—Vomiting—Bleomycin—skin cancer	0.000736	0.000782	CcSEcCtD
Vigabatrin—Anaemia—Docetaxel—skin cancer	0.000735	0.000781	CcSEcCtD
Vigabatrin—Rash—Bleomycin—skin cancer	0.00073	0.000775	CcSEcCtD
Vigabatrin—Dermatitis—Bleomycin—skin cancer	0.000729	0.000775	CcSEcCtD
Vigabatrin—Hypersensitivity—Temozolomide—skin cancer	0.000719	0.000764	CcSEcCtD
Vigabatrin—Urticaria—Fluorouracil—skin cancer	0.000715	0.000759	CcSEcCtD
Vigabatrin—Body temperature increased—Fluorouracil—skin cancer	0.000711	0.000755	CcSEcCtD
Vigabatrin—Asthenia—Temozolomide—skin cancer	0.000701	0.000744	CcSEcCtD
Vigabatrin—Cough—Docetaxel—skin cancer	0.000694	0.000737	CcSEcCtD
Vigabatrin—Pruritus—Temozolomide—skin cancer	0.000691	0.000734	CcSEcCtD
Vigabatrin—Convulsion—Docetaxel—skin cancer	0.000689	0.000732	CcSEcCtD
Vigabatrin—Nausea—Bleomycin—skin cancer	0.000688	0.00073	CcSEcCtD
Vigabatrin—Vomiting—Dactinomycin—skin cancer	0.000686	0.000729	CcSEcCtD
Vigabatrin—Rash—Dactinomycin—skin cancer	0.000681	0.000723	CcSEcCtD
Vigabatrin—Myalgia—Docetaxel—skin cancer	0.000677	0.00072	CcSEcCtD
Vigabatrin—Chest pain—Docetaxel—skin cancer	0.000677	0.00072	CcSEcCtD
Vigabatrin—Arthralgia—Docetaxel—skin cancer	0.000677	0.00072	CcSEcCtD
Vigabatrin—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—skin cancer	0.000673	0.000715	CcSEcCtD
Vigabatrin—Diarrhoea—Temozolomide—skin cancer	0.000668	0.00071	CcSEcCtD
Vigabatrin—Hypersensitivity—Fluorouracil—skin cancer	0.000663	0.000704	CcSEcCtD
Vigabatrin—Confusional state—Docetaxel—skin cancer	0.000655	0.000695	CcSEcCtD
Vigabatrin—Oedema—Docetaxel—skin cancer	0.000649	0.00069	CcSEcCtD
Vigabatrin—Dizziness—Temozolomide—skin cancer	0.000646	0.000686	CcSEcCtD
Vigabatrin—Infection—Docetaxel—skin cancer	0.000645	0.000685	CcSEcCtD
Vigabatrin—Nausea—Dactinomycin—skin cancer	0.000641	0.000681	CcSEcCtD
Vigabatrin—Nervous system disorder—Docetaxel—skin cancer	0.000637	0.000676	CcSEcCtD
Vigabatrin—Pruritus—Fluorouracil—skin cancer	0.000637	0.000676	CcSEcCtD
Vigabatrin—Skin disorder—Docetaxel—skin cancer	0.000631	0.00067	CcSEcCtD
Vigabatrin—Vomiting—Temozolomide—skin cancer	0.000621	0.000659	CcSEcCtD
Vigabatrin—Rash—Temozolomide—skin cancer	0.000616	0.000654	CcSEcCtD
Vigabatrin—Diarrhoea—Fluorouracil—skin cancer	0.000616	0.000654	CcSEcCtD
Vigabatrin—Dermatitis—Temozolomide—skin cancer	0.000615	0.000653	CcSEcCtD
Vigabatrin—Headache—Temozolomide—skin cancer	0.000612	0.00065	CcSEcCtD
Vigabatrin—Dizziness—Fluorouracil—skin cancer	0.000595	0.000632	CcSEcCtD
Vigabatrin—Musculoskeletal discomfort—Docetaxel—skin cancer	0.000592	0.000628	CcSEcCtD
Vigabatrin—Insomnia—Docetaxel—skin cancer	0.000587	0.000624	CcSEcCtD
Vigabatrin—Paraesthesia—Docetaxel—skin cancer	0.000583	0.000619	CcSEcCtD
Vigabatrin—Nausea—Temozolomide—skin cancer	0.00058	0.000616	CcSEcCtD
Vigabatrin—Somnolence—Docetaxel—skin cancer	0.000577	0.000613	CcSEcCtD
Vigabatrin—Vomiting—Fluorouracil—skin cancer	0.000572	0.000608	CcSEcCtD
Vigabatrin—Dyspepsia—Docetaxel—skin cancer	0.000572	0.000607	CcSEcCtD
Vigabatrin—Rash—Fluorouracil—skin cancer	0.000567	0.000603	CcSEcCtD
Vigabatrin—Dermatitis—Fluorouracil—skin cancer	0.000567	0.000602	CcSEcCtD
Vigabatrin—Decreased appetite—Docetaxel—skin cancer	0.000564	0.0006	CcSEcCtD
Vigabatrin—Headache—Fluorouracil—skin cancer	0.000564	0.000599	CcSEcCtD
Vigabatrin—Gastrointestinal disorder—Docetaxel—skin cancer	0.000561	0.000595	CcSEcCtD
Vigabatrin—Fatigue—Docetaxel—skin cancer	0.00056	0.000595	CcSEcCtD
Vigabatrin—Pain—Docetaxel—skin cancer	0.000555	0.00059	CcSEcCtD
Vigabatrin—Constipation—Docetaxel—skin cancer	0.000555	0.00059	CcSEcCtD
Vigabatrin—Feeling abnormal—Docetaxel—skin cancer	0.000535	0.000568	CcSEcCtD
Vigabatrin—Nausea—Fluorouracil—skin cancer	0.000534	0.000568	CcSEcCtD
Vigabatrin—Gastrointestinal pain—Docetaxel—skin cancer	0.000531	0.000564	CcSEcCtD
Vigabatrin—Body temperature increased—Docetaxel—skin cancer	0.000513	0.000545	CcSEcCtD
Vigabatrin—Abdominal pain—Docetaxel—skin cancer	0.000513	0.000545	CcSEcCtD
Vigabatrin—Hypersensitivity—Docetaxel—skin cancer	0.000478	0.000508	CcSEcCtD
Vigabatrin—Asthenia—Docetaxel—skin cancer	0.000466	0.000495	CcSEcCtD
Vigabatrin—Pruritus—Docetaxel—skin cancer	0.000459	0.000488	CcSEcCtD
Vigabatrin—Diarrhoea—Docetaxel—skin cancer	0.000444	0.000472	CcSEcCtD
Vigabatrin—Dizziness—Docetaxel—skin cancer	0.000429	0.000456	CcSEcCtD
Vigabatrin—Vomiting—Docetaxel—skin cancer	0.000413	0.000439	CcSEcCtD
Vigabatrin—Rash—Docetaxel—skin cancer	0.000409	0.000435	CcSEcCtD
Vigabatrin—Dermatitis—Docetaxel—skin cancer	0.000409	0.000435	CcSEcCtD
Vigabatrin—Headache—Docetaxel—skin cancer	0.000407	0.000432	CcSEcCtD
Vigabatrin—Nausea—Docetaxel—skin cancer	0.000386	0.00041	CcSEcCtD
